EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency

The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarctio...

Full description

Saved in:
Bibliographic Details
Published inJACC. Cardiovascular interventions Vol. 15; no. 8; p. 846
Main Authors Jia, Haibo, Dai, Jiannan, He, Luping, Xu, Yishuo, Shi, Yongfeng, Zhao, Lei, Sun, Zhiqi, Liu, Yin, Weng, Ziqian, Feng, Xue, Zhang, Dirui, Chen, Tao, Zhang, Xiling, Li, Lulu, Xu, Yousheng, Wu, Yanqing, Yang, Yining, Wang, Chunmei, Li, Lang, Li, Jianping, Hou, Jingbo, Liu, Bin, Mintz, Gary S, Yu, Bo
Format Journal Article
LanguageEnglish
Published United States 25.04.2022
Subjects
Online AccessGet full text
ISSN1876-7605
1876-7605
DOI10.1016/j.jcin.2022.01.298

Cover

Loading…
Abstract The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency. Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion. EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation. Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66). In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269).
AbstractList The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.OBJECTIVESThe aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.BACKGROUNDAngiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.METHODSEROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).RESULTSAmong 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269).CONCLUSIONSIn patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269).
The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency. Angiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion. EROSION III (Optical Coherence Tomography-Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation. Among 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66). In patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269).
Author Wu, Yanqing
Shi, Yongfeng
Feng, Xue
Li, Lulu
Jia, Haibo
Chen, Tao
Li, Jianping
Hou, Jingbo
Dai, Jiannan
Zhao, Lei
Xu, Yishuo
Yang, Yining
Zhang, Dirui
Liu, Bin
Wang, Chunmei
Weng, Ziqian
He, Luping
Xu, Yousheng
Liu, Yin
Sun, Zhiqi
Yu, Bo
Li, Lang
Zhang, Xiling
Mintz, Gary S
Author_xml – sequence: 1
  givenname: Haibo
  surname: Jia
  fullname: Jia, Haibo
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 2
  givenname: Jiannan
  surname: Dai
  fullname: Dai, Jiannan
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 3
  givenname: Luping
  surname: He
  fullname: He, Luping
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 4
  givenname: Yishuo
  surname: Xu
  fullname: Xu, Yishuo
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 5
  givenname: Yongfeng
  surname: Shi
  fullname: Shi, Yongfeng
  organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China
– sequence: 6
  givenname: Lei
  surname: Zhao
  fullname: Zhao, Lei
  organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China
– sequence: 7
  givenname: Zhiqi
  surname: Sun
  fullname: Sun, Zhiqi
  organization: Department of Cardiology, Daqing Oilfield General Hospital, Daqing, China
– sequence: 8
  givenname: Yin
  surname: Liu
  fullname: Liu, Yin
  organization: Department of Cardiology, Tianjin Chest Hospital, Tianjin, China
– sequence: 9
  givenname: Ziqian
  surname: Weng
  fullname: Weng, Ziqian
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 10
  givenname: Xue
  surname: Feng
  fullname: Feng, Xue
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 11
  givenname: Dirui
  surname: Zhang
  fullname: Zhang, Dirui
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 12
  givenname: Tao
  surname: Chen
  fullname: Chen, Tao
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 13
  givenname: Xiling
  surname: Zhang
  fullname: Zhang, Xiling
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 14
  givenname: Lulu
  surname: Li
  fullname: Li, Lulu
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 15
  givenname: Yousheng
  surname: Xu
  fullname: Xu, Yousheng
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 16
  givenname: Yanqing
  surname: Wu
  fullname: Wu, Yanqing
  organization: Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China
– sequence: 17
  givenname: Yining
  surname: Yang
  fullname: Yang, Yining
  organization: Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
– sequence: 18
  givenname: Chunmei
  surname: Wang
  fullname: Wang, Chunmei
  organization: Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
– sequence: 19
  givenname: Lang
  surname: Li
  fullname: Li, Lang
  organization: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
– sequence: 20
  givenname: Jianping
  surname: Li
  fullname: Li, Jianping
  organization: Department of Cardiology, Peking University First Hospital, Beijing, China
– sequence: 21
  givenname: Jingbo
  surname: Hou
  fullname: Hou, Jingbo
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
– sequence: 22
  givenname: Bin
  surname: Liu
  fullname: Liu, Bin
  email: liubin3333@vip.sina.com
  organization: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China. Electronic address: liubin3333@vip.sina.com
– sequence: 23
  givenname: Gary S
  surname: Mintz
  fullname: Mintz, Gary S
  organization: Cardiovascular Research Foundation, New York, New York, USA
– sequence: 24
  givenname: Bo
  surname: Yu
  fullname: Yu, Bo
  email: yubodr@163.com
  organization: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China. Electronic address: yubodr@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35367176$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1Og0AcxDemxn7oC3gwe_QC7i50AW8NwUrSimkxHsmy_Inb0AUXOPA2fZY-mSTWxNNMZia_w8zRRNcaELqnxKaE8qeDfZBK24wwZhNqs8C_QjPqe9zyOFlO_vkpmrftgRBOAo_doKmzdLhHPT5DZbRL9nHyhuM4fsYrvO2rTknQHRi8C1NclzgJU2vdqwIKvIMGTNm3qtZYabxPo22MP1X3hSNhquF8inUpjOzOp5UZCWPwLjrQcrhF16WoWri76AJ9vERp-GptknUcrjZWwyjtrFxKKqH0wCM0oNwH4ROfOoxR4Za5ywMgUrg-XeaFZJLIsWA-lyyXOXULQZwFevzlNqb-7qHtsqNqJVSV0FD3bcb4CHEJ52ycPlymfX6EImuMOgozZH_fOD_Ww2lf
ContentType Journal Article
Copyright Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jcin.2022.01.298
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1876-7605
ExternalDocumentID 35367176
Genre Randomized Controlled Trial
Multicenter Study
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
0SF
18M
1B1
1P~
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AACTN
AAEDW
AAFTH
AAIKJ
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABVKL
ACGFO
ACGFS
ADBBV
ADEZE
ADVLN
AEFWE
AEKER
AEVXI
AEXQZ
AFCTW
AFETI
AFJKZ
AFRHN
AFTJW
AGYEJ
AITUG
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
BAWUL
BLXMC
CGR
CS3
CUY
CVF
DIK
EBS
ECM
EIF
F5P
FDB
FEDTE
FNPLU
GBLVA
HVGLF
IXB
J1W
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
SDF
SEL
SES
SSZ
T5K
W8F
Z5R
7X8
AAYWO
AGCQF
APXCP
EFKBS
ID FETCH-LOGICAL-p211t-bcc1cef7e7019168ea80813221a4fb469e0ca4815bdc2c0c221286c2bcb14da03
ISSN 1876-7605
IngestDate Fri Sep 05 08:07:21 EDT 2025
Wed Feb 19 02:26:33 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords stent
ST-segment elevation myocardial infarction
optical coherence tomography
reperfusion
Language English
License Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-bcc1cef7e7019168ea80813221a4fb469e0ca4815bdc2c0c221286c2bcb14da03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 35367176
PQID 2646940662
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2646940662
pubmed_primary_35367176
PublicationCentury 2000
PublicationDate 2022-04-25
20220425
PublicationDateYYYYMMDD 2022-04-25
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-25
  day: 25
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JACC. Cardiovascular interventions
PublicationTitleAlternate JACC Cardiovasc Interv
PublicationYear 2022
References 35367171 - JACC Cardiovasc Interv. 2022 Apr 25;15(8):857-860
References_xml – reference: 35367171 - JACC Cardiovasc Interv. 2022 Apr 25;15(8):857-860
SSID ssj0060972
Score 2.5765681
Snippet The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 846
SubjectTerms Arteries
Constriction, Pathologic - etiology
Coronary Angiography - methods
Humans
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - etiology
Myocardial Infarction - therapy
Percutaneous Coronary Intervention - methods
Prospective Studies
Reperfusion
ST Elevation Myocardial Infarction - diagnostic imaging
ST Elevation Myocardial Infarction - etiology
ST Elevation Myocardial Infarction - therapy
Tomography, Optical Coherence - methods
Treatment Outcome
Title EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency
URI https://www.ncbi.nlm.nih.gov/pubmed/35367176
https://www.proquest.com/docview/2646940662
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB6UvY_d23YYG61NwkBxf9-aZbnGh6-hSyFuwZJm6MNsk9sP6a_Jb8st2dPHsdCtsezGJBA7o-3J0jvSdcxB676aqeYBj0SwkEKBQaqUkCy1XuDTw86mfqdYJ51-82ZVztnAXo9GPgWqpbdiE3_4xr-R_UIUxwFVmyf4Dsr9eCgPwGfCFJyAMz7_C-PTyQtrCcZIkOsNcpdNKvaVYjS_jufQEL-K59bktMiHzEGuxytu1kTd-mwMGYBaa67Eqc3wS2ycRScocuN_oL5EUfJqJr6l0r3dugc-iOJ5IzciOpHWgouz1iVqTO0sLVvWH40pJAFNl2XN0pjs_t3W3p8LYolU7RbG-bqvhMQVEuMSxdErzRGjTCnbX8j3i7thed8CxYGBIA30w-ZuB12cNN5MbXsjqtbYti67aupH1APH6u4J86k49iFfv1NrWu7eZeoAe2r6vbviTxcduE_dkVSOTY6XlgHd_8ADtd6-4PzhRTsr8MXpkogscaao8QSNRPkX750Y_8QzlhjEYGPMBR3jAFwx8wVWOe77gAV9wUWLFFyz5ghVfthvDle1G82S7MRx5jq4-nc7jmWU6bVi1TWljMc4pF7kvZHF-6gUilQ1ZwNbT1MmZ44WCyOr31GUZtznhMGEHHrcZZ9TJUjJ9gfbKqhSHCHsZEyT1fZKCcwh_dkYcEcguCKHDIBYXR-hdt1hLsGTyeiotRdWul-Cae6EjOxIcoZd6FZe1Lrmy7Jb61b0zx-igp91rtNesWvEG_MWGvVXI_gQFR2WI
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EROSION+III%3A+A+Multicenter+RCT+of+OCT-Guided+Reperfusion+in+STEMI+With+Early%C2%A0Infarct%C2%A0Artery%C2%A0Patency&rft.jtitle=JACC.+Cardiovascular+interventions&rft.au=Jia%2C+Haibo&rft.au=Dai%2C+Jiannan&rft.au=He%2C+Luping&rft.au=Xu%2C+Yishuo&rft.date=2022-04-25&rft.eissn=1876-7605&rft.volume=15&rft.issue=8&rft.spage=846&rft_id=info:doi/10.1016%2Fj.jcin.2022.01.298&rft_id=info%3Apmid%2F35367176&rft.externalDocID=35367176
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1876-7605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1876-7605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1876-7605&client=summon